Marcelo Sobral‐Leite

Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes

Marcelo Sobral‐Leite, Izhar Salomon, Mark Opdam et al. · Breast Cancer Research · 2019 · 131 citations · Full text

Medicine, Immunology, Oncology +15

Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, <i>BRCA1</i>-like status, tumor-infiltrating immune cells and survival

Marcelo Sobral‐Leite, Koen Van de Vijver, Magali Michaut et al. · OncoImmunology · 2018 · 120 citations · Full text

Medicine, Cancer Biology, Oncology +17

The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer

Kiki M. H. Vangangelt, Andrew R. Green, Isabelle M.F. Heemskerk et al. · International Journal of Cancer · 2020 · 71 citations · Full text

Medicine, Oncology, Breast Oncology +11

The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study

Toni Roeke, Marcelo Sobral‐Leite, Tim Dekker et al. · Breast Cancer Research and Treatment · 2017 · 67 citations

Medicine, Oncology, Breast Oncology +12

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Marcelo Sobral‐Leite, Jelle Wesseling, Vincent T.H.B.M. Smit et al. · BMC Medicine · 2015 · 57 citations · Full text

Medicine, Genetics, Oncology +13